Novel TB Regimen May Allow Shorter Treatment

Courtesy MedPage Today Infectious Disease  Thu, 04/02/2009 - 16:30

TORONTO (MedPage Today) -- Adding the fourth-generation fluoroquinolone moxifloxacin (Avelox) to standard tuberculosis therapy may allow treatment times to be shortened, an international study suggests.


 

More related items

TB-Infected Trainee Prompts Scare in Chicago
WHEELING, W.Va. (MedPage Today) -- A pediatrics resident with undiagnosed tuberculosis exposed hundreds of children and hospital workers in the Chicago area to the potentially deadly...

CDC Urges Nucleic Acid Amplification Testing for All...
ATLANTA (MedPage Today) -- Every patient with signs or symptoms of pulmonary tuberculosis should have nucleic acid amplification tests to determine a diagnosis, the CDC has recommendation.

ACAAI: Primary Immunodeficiency Is Surprisingly Common
SEATTLE (MedPage Today) -- Diagnoses of primary immunodeficiency have risen sharply in the past 30 years, making the condition possibly more common in the U.S. than tuberculosis, a researcher...

Jennifer Gianni's Fusion Pilates for Post Pregnancy &...
Get back into shape after pregnancy! Real Hospital Footage First Six Weeks Plan A MUST for getting back your pre-pregnant body. Includes real footage of Jennifer immediately after her...

Homedics SBM-200H Therapist Select Shiatsu Massaging...
The Shiatsu massaging cushion helps you enjoy state of the art relaxation....your way. This cushion features a programmable control with 3 different programs and a moving dual massage...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com